Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients-Reference-Cited by-同舟云学术

Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients

Published:2017-08-07 Issue:12 Volume:65 Page:2000-2007
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Gardiner Bradley J¹,Chow Jennifer K¹,Price Lori Lyn²³,Nierenberg Natalie E¹,Kent David M³⁴,Snydman David R¹³

Affiliation:

1. Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine

2. Institute for Clinical Research and Health Policy Studies, Tufts Medical Center

3. Tufts Clinical and Translational Science Institute, Tufts University

4. Predictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/65/12/2000/24267136/cix696.pdf

Reference36 articles.

1. Cytomegalovirus in solid organ transplantation;Razonable;Am J Transplant,2013

2. Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients;Asberg;Am J Transplant,2009

3. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients;Asberg;Am J Transplant,2007

4. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation;Kotton;Transplantation,2013

5. Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients;Asberg;Am J Transplant,2010

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update;Transplantation Reviews;2024-12

2. Prevention and management of cytomegalovirus infection and disease in kidney transplant: A consensus statement of the Transplantation Society of Taiwan;Journal of the Formosan Medical Association;2024-05

3. Real‐life use of letermovir prophylaxis for cytomegalovirus in heart transplant recipients;Clinical Transplantation;2024-04-30

4. Cytomegalovirus Treatment in Solid Organ Transplantation: An Update on Current Approaches;Annals of Pharmacotherapy;2024-03-19

5. Using a commercially available assay that measures cytomegalovirus (CMV)-specific T-cell immunity to predict protection against CMV: A prospective, blinded clinical study;Diagnostic Microbiology and Infectious Disease;2024-02